Hosted on MSN1h
Jefferies Upgrades Cardinal Health (CAH)
Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”) ...
What Is the Super Bowl Logo Conspiracy? Here's Why Fans Are Convinced This Theory Accurately Predicts the Championship Teams
The Super Bowl logo conspiracy theory states that the color way unveiled in advance accurately predicts the two teams going ...
Cardinal Health upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...